Zuvexitil 250 Tablet

Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Zuvexitil 250 is administered orally and is well absorbed from the gastrointestinal tract, achieving therapeutic concentrations in blood and tissues. It is important to complete the full prescribed course to prevent the development of resistance. The medication is generally well tolerated; however, some patients may experience adverse effects such as gastrointestinal disturbances including nausea, diarrhea, and abdominal pain, as well as hypersensitivity reactions like rash or pruritus.

Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dose adjustment may be necessary in individuals with renal impairment. Zuvexitil 250 should be used under medical supervision, and its use is contraindicated in viral infections where antibacterial therapy is not indicated. Proper diagnosis and susceptibility testing are recommended to ensure optimal therapeutic outcomes.